Antibiotice S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was RON 13.38 million compared to RON 13.78 million a year ago. Net income was RON 80.69 million compared to RON 38.51 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.975 RON | +1.54% | +1.54% | +41.58% |
1st Jan change | Capi. | |
---|---|---|
+41.58% | 287M | |
+31.52% | 690B | |
+25.05% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+14.06% | 235B | |
+5.31% | 199B | |
-9.94% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- ATB Stock
- News Antibiotice S.A.
- Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2023